Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Since 1989, they have developed innovative and reliable technologies for scientists and clinicians around the world. Their integrated portfolio of tools covers techniques of sample preparation, cell separation, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Their expertise covers research areas like immunology, stem cell biology, neuroscience, and cancer, and clinical research areas that include hematology, graft engineering, as well as apheresis. Today, Miltenyi Biotec has more than 1,300 employees in 22 countries – all dedicated to empowering scientific discovery and advancing cellular therapy. For more information, visit http://www.miltenyibiotec.com.About Terso Solutions, Inc.
Miltenyi Biotec Partners With Terso Solutions, Inc. For A Fully Automated, On-Site Inventory Management Program
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.